Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00971087 · ClinicalTrials.gov registry record · NA
Multicenter Hologic Tomosynthesis Study
A NA study, sponsored by Hologic.
- Completed
- Registry status
- NA
- Development phase
- 3,521
- Enrollment target
NCT00971087: Completed NA study, sponsored by Hologic.
NCT00971087 is a NA study that has completed, run by Hologic. The registered enrollment target is 3,521 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (151% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00971087, a NA study, has completed, sponsored by Hologic.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,521 participants
- Enrollment target
Study Summary
The purpose of this image acquisition study is to compare, in a Reader Study, the performance of Tomosynthesis (3D) to (2D FFDM) conventional images in an enriched retrospective reader study. Synthetic 2D images, generated from the tomosynthesis image, will be available to the readers to provide an over view of the anatomy similar to a scout view in CT imaging and to determine whether the 3-D images with the synthesized 2D overview are non-inferior to the 2-D images alone as determined by receiver operating characteristic (ROC) area under the curve.
Primary Outcome
ROC performance as measured by the area under the curve when comparing 3-Ds plus 3-D images to the 2-D images.
Interventions
- DEVICE Hologic Selenia Dimensions Digital Breast Tomosynthesis System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,521 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-04 |
| Phase | NA |
What the finished NCT00971087 record still lists
NCT00971087 is an interventional study that assigns participants to a tested intervention. Its 3,521 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (151% higher).
The record links to 0 conditions, and to 1 intervention - of which Hologic Selenia Dimensions Digital Breast Tomosynthesis System is the first listed.
NCT00971087 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00971087 about?
NCT00971087 is a clinical study titled "Multicenter Hologic Tomosynthesis Study". The purpose of this image acquisition study is to compare, in a Reader Study, the performance of Tomosynthesis (3D) to (2D FFDM) conventional images in an enriched retrospective reader study. Synthetic 2D images, generated from the tomosynthesis image, will be available to the readers to provide an ...
What is the current status of trial NCT00971087?
This trial is currently completed. It is a NA study. The enrollment target is 3,521 participants. The study started on 2009-09. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00971087?
The interventions under investigation include: Hologic Selenia Dimensions Digital Breast Tomosynthesis System (DEVICE).
Who is sponsoring clinical trial NCT00971087?
This trial is sponsored by Hologic, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00971087's enrollment target sits among peer trials
3,521 36th of 2000 higher than 1,965 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00260559 · 3,500 participants
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
- NCT01612949 · 3,500 participants
Facial Analysis to Classify Difficult Intubation
- NCT02398786 · 3,500 participants
Myotonic Dystrophy Family Registry
- NCT03486873 · 3,500 participants · Phase 3
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia